A jury in California convicted Rowland Marcus Andrade of wire fraud and money laundering in connection with the sale of AML ...

The new findings are the first to describe distributions and perturbations of low-density granulocyte and normal-density neutrophil subsets in myelodysplastic syndromes (MDS), acute myeloid leukemia ...

Rowland Marcus Andrade, founder of the AML Bitcoin cryptocurrency, has been convicted of wire fraud and money laundering in ...

Swedish company Cantargia has enrolled the first patient in the Phase Ib/IIa trial of nadunolimab for treating individuals ...

Turkey’s Capital Markets Board (CMB) has introduced a comprehensive regulatory framework for crypto companies under its ...

Anthony Stein, MD, assessed total marrow and lymphoid irradiation with post-transplant cyclophosphamide in patients with ...

Regtech Sumsub has introduced the latest update in case management and AI-driven AML screening to help compliance teams boost ...

Actimab-A is a humanized anti-CD33 antibody conjugated to Actinium-225 (Ac-225). With its potent alpha-particle payload ...

Early measurable residual disease clearance is linked to better outcomes in acute myeloid leukemia, study suggests.

The return of Donald Trump to the White House signals dramatic shifts in sanctions policy and anti-money laundering ...

A case involving the Panama Canal, Jack Abramoff, and Bitcoin may have reached its conclusion with a March 12 jury verdict.

Gene mutations in acute myeloid leukemia (AML) cells can guide treatment options, and machine learning can rapidly guess the ...